- Home
- BBIO vs APPF Comparison
BBIO vs APPF Comparison
Compare BBIO & APPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- APPF
- Stock Information
- Founded
- BBIO 2015
- APPF 2006
- Country
- BBIO United States
- APPF United States
- Employees
- BBIO N/A
- APPF N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- APPF Computer Software: Prepackaged Software
- Sector
- BBIO Health Care
- APPF Technology
- Exchange
- BBIO Nasdaq
- APPF Nasdaq
- Market Cap
- BBIO 8.8B
- APPF 9.5B
- IPO Year
- BBIO 2019
- APPF 2015
- Fundamental
- Price
- BBIO $49.08
- APPF $275.32
- Analyst Decision
- BBIO Strong Buy
- APPF Buy
- Analyst Count
- BBIO 16
- APPF 6
- Target Price
- BBIO $61.69
- APPF $302.50
- AVG Volume (30 Days)
- BBIO 2.9M
- APPF 433.7K
- Earning Date
- BBIO 08-05-2025
- APPF 10-23-2025
- Dividend Yield
- BBIO N/A
- APPF N/A
- EPS Growth
- BBIO N/A
- APPF 64.56
- EPS
- BBIO N/A
- APPF 5.55
- Revenue
- BBIO $235,812,000.00
- APPF $862,674,000.00
- Revenue This Year
- BBIO $106.33
- APPF $21.09
- Revenue Next Year
- BBIO $54.30
- APPF $17.60
- P/E Ratio
- BBIO N/A
- APPF $49.63
- Revenue Growth
- BBIO 7.62
- APPF 19.47
- 52 Week Low
- BBIO $21.72
- APPF $189.01
- 52 Week High
- BBIO $51.86
- APPF $326.04
- Technical
- Relative Strength Index (RSI)
- BBIO 55.76
- APPF 54.15
- Support Level
- BBIO $48.03
- APPF $264.95
- Resistance Level
- BBIO $51.86
- APPF $273.50
- Average True Range (ATR)
- BBIO 1.95
- APPF 9.80
- MACD
- BBIO -0.08
- APPF -3.31
- Stochastic Oscillator
- BBIO 71.55
- APPF 19.44
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About APPF AppFolio Inc.
AppFolio Inc provides cloud-based software solutions for the real estate industry. Its property management software offers property managers an end-to-end solution to their business needs. The group's products include cloud-based property management software (Appfolio Property Manager). Its solutions are AppFolio Property Manager Core, AppFolio Property Manager Plus, and AppFolio Property Manager Max. It also offers value-added services, such as screening, risk mitigation, and electronic payment services. Its markets are Single-Family, Multifamily, Student Housing, Affordable Housing, Community Associations, Commercial, and Investment Management. The business activity of the firm predominantly functions in the United States and it generates revenue in the form of subscription fees.